Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Semcon develops AI-driven data management for Stena Line

Combining the latest in AI, data mining and information architecture means that Semcon is now assisting the Stena Line shipping company with a new pilot project for development of a unique data management solution. This solution is paving the way for new digital, sustainable and profitable services at Stena Line.“Stena Line is embarking upon a fantastic data transformation initiative, and we are very pleased to have the opportunity to join them on their journey,” says Carl-Johan Aldén, Global Business Director Digital Solutions at Semcon.Stena Line is focusing widely on digitisation –

HemoCue AB, the pioneer and global leader in hemoglobin (Hb) point-of-care testing (POCT) to further strengthen national activities in the combat against anemia in India

HemoCue AB report fruitful discussions, continued support and new activities related to health initiatives, following the participation at the High-Level Business Delegation in New Delhi and Mumbai, on December 2-4, 2019.In 2019, Sweden and India celebrate 10 years of collaboration under a Memorandum of Understanding (MoU) on Health. It also marks 10 years of our local presence as HemoCue India. Globally, as well as locally, we share our commitment in supporting national and global Public Health Initiatives. Already in 2015, HemoCue launched the initiative “Embrace Health – Unite to Screen

Correction: English version now includes attached presentation material

12 December 2019: During Kvaerner’s capital market update presentations today, the company comments on a series of news. The ambition to grow annual revenues above NOK 10 billion within 2023 is confirmed, and it simultaneously repeats that the financial results will in the short term first decline in 2020. The company also guides on several key figures for the operations. In addition, the company today announces strategic cooperation with other leading contractors for joint delivery of future projects. Key financial figures Kvaerner today presents the ambition to grow annual revenues

Savings programme for employees

Reference is made to the stock exchange announcement dated 14 March 2019 on the introduction  of a share savings program for employees of SpareBank 1 SR-Bank . The purpose of the programme is to motivate employees to become co-owners of the bank and also to raise interest concerning the bank’s strategy and results. The Board of Directors of SpareBank 1 SR-Bank has decided to continue the scheme for 2020. Employees are invited to save a fixed amount per month to buy shares in the bank. Employees who register for the savings programme can choose to subscribe the shares corresponding to

Redeye initiates coverage of Strax

We initiate coverage of Strax – one of Europe’s largest specialized distributors in mobile accessories. Strax combines its distribution platform with own brands, which is a unique strategy that provides Strax’s own brands immediate exposure to a vast distribution network of 40 000 points of sales. We argue that the market overlooks the strength of the business model and Strax’s track record in growing its own brands. Read more and download the research update: http://bit.ly/2LMrCYm Start following companies at Redeye to receive the latest equity research within Life Science and

Imfinzi approved in China for the treatment of unresectable, Stage III non-small cell lung cancer based on the Phase III PACIFIC trial

12 December 2019 07:00 GMT   Imfinzi approved in China for the treatment of unresectable, Stage IIInon-small cell lung cancer based on the Phase III PACIFIC trial   Imfinzi is the only immunotherapy approved in China to treat patientsin the curative-intent Stage III setting following chemoradiation treatment AstraZeneca today announced that it has received marketing authorisation from China's National Medical Products Administration (NMPA) for Imfinzi (durvalumab) for the treatment of patients with unresectable, Stage III non-small cell lung cancer (NSCLC) whose disease

Saudi Telecom Company selects IFS to improve customer experience

IFS’s leading workforce scheduling solution to radically improve the efficiency of 5,000 field service engineers London, December 12, 2019 – IFS , the global enterprise applications company, announces that Saudi Telecom Company  (STC), a world class digital leader providing innovative services and platforms to our customers and enabling the digital transformation of the MENA region, has selected IFS Service Management  to increase

Aker Solutions to Provide Subsea Production System for Phase Two of Aker BP's Ærfugl

December 12, 2019 - Aker Solutions has been awarded a contract from Aker BP to deliver the subsea production system for the second phase of the Ærfugl development offshore Norway.The subsea delivery will include wellheads, vertical subsea trees, satellite structures, control systems, a tie-in module and about 30 kilometers of umbilicals. The contract has a value of about NOK 700 million, which will be booked as order intake in the fourth quarter. "The subsea alliance between Aker Solutions, Subsea 7 and Aker BP has already demonstrated great value through a series of subsea project

Moberg Pharma comments on the results of the North American Phase 3 study with MOB-015

STOCKHOLM, December 12[th], 2019, Moberg Pharma AB (OMX: MOB): On Monday the topline results were presented from the first study in the Phase 3 program for MOB-015, where the primary endpoint and the two key secondary endpoints were met. Since the results are somewhat contradictory and the company has received many questions, we want to clarify the various study parameters as well as our view of the current status and next step.The company’s comment on the resultsOn Monday December 9[th], the topline results were presented from the first of two clinical studies in the Phase 3 program for

The Green Assets Wallet – first blockchain for green bond impact data

Press release, 12 December, 8.00 am CET.Today sees the launch of the Green Assets Wallet, an innovative blockchain database, for issuers and investors of green bonds. A co-creation of leading capital market actors, green finance experts and technology innovators, the Green Assets Wallet is a transparent platform for trusted green bond data. Its objective is to unlock greater volumes of credible investment opportunities that deliver environmental impact.“After two years of intensive development work, we and our partners are excited to see the Green Assets Wallet going into full service.

Wärtsilä to divest its ELAC Nautik business

Wärtsilä Corporation, Press release, 12 December 2019 at 9 am EETThe technology group Wärtsilä announces the divestment of shares in Wärtsilä ELAC Nautik GmbH (ELAC Nautik) to Cohort plc, a UK listed company, specialising in defence, security and related market sectors. ELAC Nautik became part of Wärtsilä as a result of the acquisition of L-3 Communications MSI in 2015. Its main market focus is on hydroacoustic products, including sonars, underwater communication systems and echo systems for small and medium sized military submarines. The company is located in Kiel, Germany and currently

Gold&Green Foods known for its Pulled Oats to cooperate with UNICEF

Gold&Green Foods Ltd and UNICEF Finland have signed a three-year partnership agreement for 2020–2022. The cooperation will be seen in Pulled Oats products. Gold&Green Foods has committed to supporting UNICEF’s operations through donations for three years. The first step in the cooperation between Gold&Green Foods and UNICEF Finland will be taken in January when 20 cents for every Pulled Oats Nude product package sold during the first months of 2020 will be donated to UNICEF’s work for the most vulnerable children. UNICEF works all over the world to ensure children’s rights to

World-class Performance with Assistance of Artificial Intelligence

In the latest version of Ortoma Treatment Solution, OTS 4, Ortoma has introduced support of Artificial Intelligence. The system drastically reduces the time needed for pre-operatively planning of a hip implant in 3D, which has created a big interest for the company’s unique solution.Performance has been a focus area during the development of the latest version of Ortoma Treatment Solution (OTS). With OTS 4, an automatic AI-analysis, which forms the basis for the pre-operative planning, is made. The analysis does not take more than about 30 seconds and includes a suggestion for suitable

4th Quarter Results

ROYAL BANK OF CANADA 2019 ANNUAL REPORT (PART II OF II)   To view the 2019 Annual Report in PDF, please click on the link below:  http://www.rns-pdf.londonstockexchange.com/rns/5883W_1-2019-12-11.pdf      Caution regarding forward-looking statements   From time to time, we make written or oral forward-looking statements within the meaning of certain securities laws, including the "safe harbour" provisions of the United States Private Securities Litigation Reform Act of 1995 and any applicable Canadian securities legislation. We may make forward-looking statements in

Castellum acquires properties in central Västerås

Castellum has acquired two office buildings in central Västerås from the Imperia Fastigheter AB real estate company. Occupancy will occur December 18 this year, and January 9, 2020. The acquisition comprises two office buildings: Kol 13 at Kopparbergsvägen 25 and Kungsängen 14 at the Pilgatan 4 address, with a total leasable area of approx. 7,551 sq.m. The acquisition price will come to MSEK 217, after deduction for deferred tax of MSEK 11. The transaction includes unutilized building rights valued at MSEK 5, which can enable new office-space construction covering approx. 2,500 sq.m. in

Nordic Nanovector provides update on LYMRIT 37-05 Phase 1 DLBCL trial

Oslo, Norway, 12 December 2019 Nordic Nanovector ASA (OSE: NANO) reports an update on its LYMRIT 37-05 Phase 1 trial of Betalutin® in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) who are not eligible for autologous stem cell transplantation (SCT). DLBCL is an aggressive form of non-Hodgkin's lymphoma (NHL) and accounts for up to 43% of all cases, making it the most common type of NHL. This open-label, dose-escalation safety trial is designed to assess the safety, tolerability, pharmacokinetic profile and preliminary anti-tumour activity of Betalutin® in

Kvaerner guides for financial results and announces strategic cooperation at Capital Market Update

12 December 2019: During Kvaerner’s capital market update presentations today, the company comments on a series of news. The ambition to grow annual revenues above NOK 10 billion within 2023 is confirmed, and it simultaneously repeats that the financial results will in the short term first decline in 2020. The company also guides on several key figures for the operations. In addition, the company today announces strategic cooperation with other leading contractors for joint delivery of future projects. Key financial figures Kvaerner today presents the ambition to grow annual revenues

Kyocera and TactoTek® Collaborate on Injection Molded Structural Electronics (IMSE™) Solutions

Technical and commercial assessment of complementary technologies to support market push.OULU, FINLAND/KYOTO, JAPAN (12 December 2019) – Today, Kyocera and TactoTek announced the signing of a marketing agreement which aims to bring IMSE™ solutions to several new market segments, including industrial and automotive components, electronic devices, and more. The Kyocera Group has global operations in a wide range of business segments—offering industrial and automotive components, communications equipment, electronic devices, environmental and energy related technologies, and consumer

Brighter's ongoing rights issue does not require any prior approval

Following media's comments to Brighter's press release earlier this evening on December 11, 2019 in which the company comments on the Swedish Securities Council's statement on the ongoing rights issue without organized trading of subscription rights, the company want to make the following clarification: The headlines of the comments are grossly misleading, inaccurate and can be interpreted as if the ongoing issue will need approval, which is not the case. The statement from the Swedish Securities Council states that, in light of the issue's construction, Brighter should have applied for

Company announcement from SGL TransGroup International A/S

Company announcement no. 17 Acquisition opportunity funded by Subsequent Bond Issue SGLT Group continues its strategy to assess synergetic acquisition opportunities with strategic fit at favourable terms. Currently, SGLT Group has identified an acquisition opportunity which will add to the scale of the SGLT Group, increase profitability, and should positively impact the consolidated leverage ratio of the SGLT Group. This acquisition opportunity is likely to materialise during December 2019 or January 2020. Consequently, SGL TransGroup International A/S contemplates a Subsequent

Securitas acquires leading electronic security company in Australia

Securitas is strengthening its client value proposition in the Australian security market through the acquisition of Fredon Security, a leading electronic security company in Australia. The purchase price is estimated to MAUD 32 (MSEK 210).Securitas has entered into an agreement to acquire Fredon Security, founded in 2012 as a division within Fredon Group, an Australian engineering and building services company. Fredon Security is specialized in high-end electronic security solutions including system design, engineering, installation, commissioning and maintenance. The company has

Oskar Mühlbach appointed President and CEO of Raketech

The Board of Directors of Raketech Group Holding P.L.C, a leading online affiliate and content marketing company, has appointed Oskar Mühlbach as the new President and CEO. Since April 2019, Oskar Mühlbach has held the role of Chief Operating Officer (COO).Oskar Mühlbach has solid experience from some of the Nordic region's most successful brands in e-commerce, online casinos and sports betting. He has played a significant role in developing the company's strategy for future expansion together with the Board of Directors and the other members of the management team. “Oskar has a clear

Inhalation Sciences receives order worth approx. 3 MSEK from leading big pharma company

(Stockholm December 11, 2019) Inhalation Sciences (ISAB) has received an order for a PreciseInhale aerosol R&D system with an intratracheal exposure module, a Nose-Only exposure module and ISAB’s leading in vitro simulation module DissolvIt. The total purchase order is worth 317,000 USD or 2992k SEK (current currency conversion rate).The order comes from a leading pharmaceutical company, and is their first order placed with Inhalation Sciences. The buyer has an extensive pipeline and this PreciseInhale-system is planned to be used at one of the company’s US-based affiliates. With this

The Swedish Securities Council states that the lack of organized trading in subscription rights requires prior approval

The Swedish Securities Council has today commented on Brighter's rights issue without organized subscription rights trading, which was published on November 18, 2019 (the "Benefit Issue"), and states that a rights issue without organized trading in subscription rights requires a prior approval of the Swedish Securities Council. The Board of Directors of Brighter has, with surprise, taken part of the statement of the Swedish Securities Committee, as it is the Board's continued assessment that Brighter and its shareholders are benefited by the design of the Rights Issue. Regarding the

There are no items matching the current filter
There are no more items matching the current filter
Back to top